[1] |
WANG HM, SHAN XF, ZHANG M, et al. Homogeneous and heterogeneous risk and prognostic factors for lung metastasis in colorectal cancer patients[J]. BMC Gastroenterol, 2022, 22( 1): 193. DOI: 10.1186/s12876-022-02270-5.
|
[2] |
PEREIRA AAL, REGO JFM, MORRIS V, et al. Association between KRAS mutation and lung metastasis in advanced colorectal cancer[J]. Br J Cancer, 2015, 112( 3): 424- 428. DOI: 10.1038/bjc.2014.619.
|
[3] |
CHO JH, HAMAJI M, ALLEN MS, et al. The prognosis of pulmonary metastasectomy depends on the location of the primary colorectal cancer[J]. Ann Thorac Surg, 2014, 98( 4): 1231- 1237. DOI: 10.1016/j.athoracsur.2014.05.023.
|
[4] |
ELIAS D, SIDERIS L, POCARD M, et al. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease[J]. Ann Surg Oncol, 2004, 11( 3): 274- 280. DOI: 10.1245/aso.2004.03.085.
|
[5] |
STEWART CL, WARNER S, ITO K, et al. Cytoreduction for colorectal metastases: Liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?[J]. Curr Probl Surg, 2018, 55( 9): 330- 379. DOI: 10.1067/j.cpsurg.2018.08.004.
|
[6] |
VEGA EA, SALEHI O, NICOLAESCU D, et al. Failure to cure patients with colorectal liver metastases: The impact of the liver surgeon[J]. Ann Surg Oncol, 2021, 28( 12): 7698- 7706. DOI: 10.1245/s10434-021-10030-0.
|
[7] |
MINAGAWA M, MAKUUCHI M, TORZILLI G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results[J]. Ann Surg, 2000, 231( 4): 487- 499. DOI: 10.1097/00000658-200004000-00006.
|
[8] |
HASSELGREN K, ISAKSSON B, ARDNOR B, et al. Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease[J]. Ann Transl Med, 2020, 8( 4): 109. DOI: 10.21037/atm.2019.12.125.
|
[9] |
MISE Y, KOPETZ S, MEHRAN RJ, et al. Is complete liver resection without resection of synchronous lung metastases justified?[J]. Ann Surg Oncol, 2015, 22( 5): 1585- 1592. DOI: 10.1245/s10434-014-4207-3.
|
[10] |
ALBERTSMEIER M, RIEDL K, STEPHAN AJ, et al. Improved survival after resection of colorectal liver metastases in patients with unresectable lung metastases[J]. HPB(Oxford), 2020, 22( 3): 368- 375. DOI: 10.1016/j.hpb.2019.07.004.
|
[11] |
MAITHEL SK, GINSBERG MS, D’AMICO F, et al. Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer[J]. J Am Coll Surg, 2010, 210( 1): 31- 38. DOI: 10.1016/j.jamcollsurg.2009.09.032.
|
[12] |
ARDITO F, PANETTIERI E, VELLONE M, et al. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas[J]. Surgery, 2019, 165( 4): 712- 720. DOI: 10.1016/j.surg.2018.09.005.
|
[13] |
PROCOPIO F, VIGANÒ L, CIMINO M, et al. Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study[J]. Eur J Surg Oncol, 2020, 46( 5): 818- 824. DOI: 10.1016/j.ejso.2019.12.004.
|
[14] |
SAKAI N, FURUKAWA K, TAKAYASHIKI T, et al. Recurrence patterns and their effects on clinical outcomes after R1 resection of colorectal liver metastases: A propensity score-matched analysis[J]. Langenbecks Arch Surg, 2021, 406( 8): 2739- 2747. DOI: 10.1007/s00423-021-02096-x.
|
[15] |
KIM NR, ALHOTHAIFI ED, HAN DH, et al. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: A retrospective cohort study[J]. World J Surg Oncol, 2023, 21( 1): 169. DOI: 10.1186/s12957-023-03042-5.
|
[16] |
de HAAS RJ, WICHERTS DA, FLORES E, et al. R1 resection by necessity for colorectal liver metastases: Is it still a contraindication to surgery?[J]. Ann Surg, 2008, 248( 4): 626- 637. DOI: 10.1097/SLA.0b013e31818a07f1.
|
[17] |
TRUANT S, SÉQUIER C, LETEURTRE E, et al. Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens[J]. HPB(Oxford), 2015, 17( 2): 176- 184. DOI: 10.1111/hpb.12316.
|
[18] |
PENCOVICH N, HOULI R, LUBEZKY N, et al. R1 resection of colorectal liver metastasis- What is the cost of marginal resection?[J]. J Surg Oncol, 2019, 119( 3): 347- 354. DOI: 10.1002/jso.25321.
|
[19] |
MCVEY JC, SASAKI K, MARGONIS GA, et al. The impact of resection margin on overall survival for patients with colon cancer liver metastasis varied according to the primary cancer location[J]. HPB(Oxford), 2019, 21( 6): 702- 710. DOI: 10.1016/j.hpb.2018.11.001.
|
[20] |
AYEZ N, LALMAHOMED ZS, EGGERMONT AMM, et al. Outcome of microscopic incomplete resection(R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy[J]. Ann Surg Oncol, 2012, 19( 5): 1618- 1627. DOI: 10.1245/s10434-011-2114-4.
|
[21] |
ANDREOU A, ALOIA TA, BROUQUET A, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy[J]. Ann Surg, 2013, 257( 6): 1079- 1088. DOI: 10.1097/SLA.0b013e318283a4d1.
|
[22] |
SASAKI K, MARGONIS GA, MAITANI K, et al. The prognostic impact of determining resection margin status for multiple colorectal metastases according to the margin of the largest lesion[J]. Ann Surg Oncol, 2017, 24( 9): 2438- 2446. DOI: 10.1245/s10434-017-5904-5.
|
[23] |
OSHI M, MARGONIS GA, SAWADA Y, et al. Higher tumor burden neutralizes negative margin status in hepatectomy for colorectal cancer liver metastasis[J]. Ann Surg Oncol, 2019, 26( 2): 593- 603. DOI: 10.1245/s10434-018-6830-x.
|
[24] |
MARGONIS GA, SASAKI K, ANDREATOS N, et al. KRAS mutation status dictates optimal surgical margin width in patients undergoing resection of colorectal liver metastases[J]. Ann Surg Oncol, 2017, 24( 1): 264- 271. DOI: 10.1245/s10434-016-5609-1.
|
[25] |
WANG HW, WANG LJ, JIN KM, et al. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation(GAME) score for colorectal liver metastasis[J]. J Surg Oncol, 2021, 124( 4): 619- 626. DOI: 10.1002/jso.26557.
|
[26] |
ANDREOU A, KNITTER S, SCHMELZLE M, et al. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival[J]. Surgery, 2021, 169( 5): 1061- 1068. DOI: 10.1016/j.surg.2020.11.024.
|
[27] |
VIGANÒ L, PROCOPIO F, CIMINO MM, et al. Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort[J]. Ann Surg Oncol, 2016, 23( 4): 1352- 1360. DOI: 10.1245/s10434-015-5009-y.
|
[28] |
NISHIOKA Y, PAEZ-ARANGO N, BOETTCHER FO, et al. Neither surgical margin status nor somatic mutation predicts local recurrence after R0-intent resection for colorectal liver metastases[J]. J Gastrointest Surg, 2022, 26( 4): 791- 801. DOI: 10.1007/s11605-021-05173-0.
|
[29] |
TRANCHART H, CHIRICA M, FARON M, et al. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: Reappraisal in the era of modern chemotherapy[J]. World J Surg, 2013, 37( 11): 2647- 2654. DOI: 10.1007/s00268-013-2186-3.
|
[30] |
LAURENT C, ADAM JP, DENOST Q, et al. Significance of R1 resection for advanced colorectal liver metastases in the era of modern effective chemotherapy[J]. World J Surg, 2016, 40( 5): 1191- 1199. DOI: 10.1007/s00268-016-3404-6.
|
[31] |
WEBER SM, JARNAGIN WR, DEMATTEO RP, et al. Survival after resection of multiple hepatic colorectal metastases[J]. Ann Surg Oncol, 2000, 7( 9): 643- 650. DOI: 10.1007/s10434-000-0643-3.
|
[32] |
MOHAMMAD WM, MARTEL G, MIMEAULT R, et al. Evaluating agreement regarding the resectability of colorectal liver metastases: A national case-based survey of hepatic surgeons[J]. HPB(Oxford), 2012, 14( 5): 291- 297. DOI: 10.1111/j.1477-2574.2012.00440.x.
|
[33] |
WICHERTS DA, MILLER R, DE HAAS RJ, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases[J]. Ann Surg, 2008, 248( 6): 994- 1005. DOI: 10.1097/SLA.0b013e3181907fd9.
|
[34] |
PICARDO A, KARPOFF HM, NG B, et al. Partial hepatectomy accelerates local tumor growth: Potential roles of local cytokine activation[J]. Surgery, 1998, 124( 1): 57- 64. DOI: 10.1016/s0039-6060(98)70075-3.
|
[35] |
ADAM R, LAURENT A, AZOULAY D, et al. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors[J]. Ann Surg, 2000, 232( 6): 777- 785. DOI: 10.1097/00000658-200012000-00006.
|
[36] |
BRISTOW RE, TOMACRUZ RS, ARMSTRONG DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis[J]. J Clin Oncol, 2023, 41( 25): 4065- 4076. DOI: 10.1200/JCO.22.02765.
|
[37] |
ALLARD MA, ADAM R, GIULIANTE F, et al. Long-term outcomes of patients with 10 or more colorectal liver metastases[J]. Br J Cancer, 2017, 117( 5): 604- 611. DOI: 10.1038/bjc.2017.218.
|
[38] |
TANAKA K, MURAKAMI T, YABUSHITA Y, et al. Maximal debulking liver resection as a beneficial treatment strategy for advanced and aggressive colorectal liver metastases[J]. Anticancer Res, 2014, 34( 10): 5547- 5554.
|
[39] |
ADAM R, KITANO Y, ABDELRAFEE A, et al. Debulking surgery for colorectal liver metastases: Foolish or chance?[J]. Surg Oncol, 2020, 33: 266- 269. DOI: 10.1016/j.suronc.2020.02.008.
|
[40] |
COHEN PA, POWELL A, BÖHM S, et al. Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data[J]. Gynecol Oncol, 2019, 154( 2): 441- 448. DOI: 10.1016/j.ygyno.2019.04.679.
|
[41] |
YANG D, KHAN S, SUN Y, et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer[J]. JAMA, 2011, 306( 14): 1557- 1565. DOI: 10.1001/jama.2011.1456.
|
[42] |
BRAICU EI, CHEKEROV R, RICHTER R, et al. HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse[J]. Ann Surg Oncol, 2014, 21( 3): 955- 962. DOI: 10.1245/s10434-013-3347-1.
|
[43] |
LIU JF, KINDELBERGER D, DOYLE C, et al. Predictive value of circulating tumor cells(CTCs) in newly-diagnosed and recurrent ovarian cancer patients[J]. Gynecol Oncol, 2013, 131( 2): 352- 356. DOI: 10.1016/j.ygyno.2013.08.006.
|
[44] |
LAUBY A, COLOMBAN O, CORBAUX P, et al. The increasing prognostic and predictive roles of the tumor primary chemosensitivity assessed by CA-125 elimination rate constant K(KELIM) in ovarian cancer: A narrative review[J]. Cancers(Basel), 2021, 14( 1): 98. DOI: 10.3390/cancers14010098.
|
[45] |
YOU B, FREYER G, GONZALEZ-MARTIN A, et al. The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas[J]. Cancer Treat Rev, 2021, 100: 102294. DOI: 10.1016/j.ctrv.2021.102294.
|
[1] | Junqing WANG, Yongjun CHEN. Surgical intervention strategies for liver metastasis of neuroendocrine tumors[J]. Journal of Clinical Hepatology, 2024, 40(7): 1301-1306. doi: 10.12449/JCH240703 |
[2] | Shangdan XIE, Qunchao HU, Haiyan ZHU. Research advances in the treatment of cervical cancer with liver metastasis[J]. Journal of Clinical Hepatology, 2024, 40(7): 1307-1311. doi: 10.12449/JCH240704 |
[3] | Xiangyu WANG, Jinhong CHEN. Treatment of metastatic liver cancer: Current status and future perspectives[J]. Journal of Clinical Hepatology, 2024, 40(7): 1289-1294. doi: 10.12449/JCH240701 |
[4] | Xiaoqing WANG, Jie LONG, Fei WANG, Zhexiong LIAN. Impact of cancer-associated fibroblasts on immunotherapy and liver metastasis in colorectal cancer[J]. Journal of Clinical Hepatology, 2024, 40(6): 1183-1190. doi: 10.12449/JCH240618 |
[5] | Jiachao ZHANG, Zhensheng ZHANG, Pingping CHEN, Rong TANG, Yongchao ZENG, Qizhao LI. Complete remission after comprehensive treatment of lung metastases following liver cancer surgery: A case report[J]. Journal of Clinical Hepatology, 2021, 37(6): 1432-1434. doi: 10.3969/j.issn.1001-5256.2021.06.044 |
[6] | Xuemin LI, Hao WANG, Junjie WANG. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis[J]. Journal of Clinical Hepatology, 2021, 37(3): 522-526. doi: 10.3969/j.issn.1001-5256.2021.03.006 |
[7] | Chinese College of Surgeons, Chinese Medical Doctor Association, Chinese Society Gastrointestinal Surgery, Chinese Society of Surgery, Chinese Medical Association, Chinese Society of Colorectal Surgery, Chinese Society of Surgery, Chinese Medical Association, Section of Colorectal Oncology, Chinese Society of Oncology, Chinese Medical Association, Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association, Colorectal Cancer Professional Committee, Chinese Medical Doctor Association, Colorectal Cancer Expert Committee, Chinese Society of Clinical Oncology, Chinese College of Colorectal Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association, Metastasis Research Committee, Anorectal Branch of Chinese Medical Doctor Association, Colorectal Liver Metastases Professional Committee, China International Exchange and Promotive Association for Medical and Health Care. China guideline for diagnosis and comprehensive treatment of colorectal liver metastases (2020 edition)[J]. Journal of Clinical Hepatology, 2021, 37(3): 543-553. doi: 10.3969/j.issn.1001-5256.2021.03.009 |
[8] | Xiangqian HUANG, Xiaomeng YAN, Mingda ZHANG, Jing WU, Jianhong CHEN. Association between nonalcoholic fatty liver disease and colorectal neoplasms[J]. Journal of Clinical Hepatology, 2021, 37(12): 2947-2950. doi: 10.3969/j.issn.1001-5256.2021.12.045 |
[9] | Gao BenJian, Luo Jia, Liu Ying, Yang XiaoLi, Su Song, Li Bo. Efficacy and safety of laparoscopic versus open liver resection in treatment of colorectal cancer liver metastasis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(3): 573-579. doi: 10.3969/j.issn.1001-5256.2020.03.021 |
[10] | Li Jiang, Hou Yu, Cai XiaoBei, Xu ChengLei, Yi GenFa. Clinical effect of local treatment based on limited segmental resection in improving the prognosis of liver oligometastasis after surgery for colorectal cancer[J]. Journal of Clinical Hepatology, 2020, 36(8): 1763-1767. doi: 10.3969/j.issn.1001-5256.2020.08.017 |
[11] | Liao Yang, Li ShengWei. Current status of associating liver partition and portal vein ligation for staged hepatectomy in treatment of liver metastasis of colorectal cancer[J]. Journal of Clinical Hepatology, 2019, 35(12): 2805-2808. doi: 10.3969/j.issn.1001-5256.2019.12.035 |
[12] | Liu SiFu, Xie ZhengYuan. Association between nonalcoholic fatty liver disease and colorectal tumors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2091-2094. doi: 10.3969/j.issn.1001-5256.2019.09.046 |
[13] | Society for Minimally Invasive Surgery, Chinese Research Hospital Association. Technical guidelines for simultaneous laparoscopic and robotic resection of colorectal cancer with liver metastasis ( Revised in 2017)[J]. Journal of Clinical Hepatology, 2018, 34(3): 494-497. doi: 10.3969/j.issn.1001-5256.2018.03.007 |
[14] | Ding XiaoYan, Chen JingLong, Sun Wei, Li WenDong, Guo XiaoDi, Shen YanJun, Sun ShaSha, Zhuang XiuFen. Influence of time schedule of radiofrequency ablation on the safety and prognosis of patients with colorectal cancer liver metastasis receiving XELOX regimen: A single-center clinical study[J]. Journal of Clinical Hepatology, 2018, 34(12): 2603-2609. doi: 10.3969/j.issn.1001-5256.2018.12.019 |
[15] | Wang DongXu, Huo TingTing, Tian YaoWen, Zhao Lei. Current status of research on microRNA associated with colorectal cancer liver metastasis[J]. Journal of Clinical Hepatology, 2016, 32(12): 2387-2390. doi: 10.3969/j.issn.1001-5256.2016.12.034 |
[16] | Wang Xin, Zhang Hui, He XiaoJun, Li XinHui, Liu Yang, Zhang HongYi. Clinical effect of precise sequential interventional therapy in patients with unresectable hepatic metastasis after surgery for colorectal cancer[J]. Journal of Clinical Hepatology, 2016, 32(3): 518-521. doi: 10.3969/j.issn.1001-5256.2016.03.025 |
[17] | Jian QianHong, Zheng FangRong, Yan Xiong. Current status of research on transcatheter arterial chemoembolization in treatment of colorectal cancer liver metastasis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1216-1219. doi: 10.3969/j.issn.1001-5256.2016.06.047 |
[18] | Li Zhao, Zhu JiYe. Treatment of pancreatic neuroendocrine tumor with liver metastases[J]. Journal of Clinical Hepatology, 2015, 31(5): 668-670. doi: 10.3969/j.issn.1001-5256.2015.05.007 |
[19] | Ji Ru, Dou KeFeng, Xu Hui. Prevention and management of recurrence and metastasis of hepatocellular carcinoma after liver transplantation[J]. Journal of Clinical Hepatology, 2014, 30(1): 7-10. doi: 10.3969/j.issn.1001-5256.2014.01.003 |
[20] | Wang Min, Wang Shuang, Jin HongYong, An LiXue, Ji FuJian, Liu Zhuo, Cao Hong. Surgical treatment of rectal cancer with synchronous hepatic metastases[J]. Journal of Clinical Hepatology, 2012, 28(1): 17-20. |